材料科学
纳米载体
内吞作用
细胞内
细胞毒性
光热治疗
纳米技术
纳米颗粒
生物物理学
阿霉素
药物输送
活力测定
癌细胞
靶向给药
毒品携带者
细胞粘附
细胞外
细胞
癌症
体外
生物化学
化疗
生物
遗传学
化学
作者
Ming Zhu,Xin‐Di Zhu,Mei Long,Xing Lai,Yihang Yuan,Yanhu Huang,Lele Zhang,Yuhao Gao,Jianbin Shi,Qin Lu,Peng Sun,Jonathan F. Lovell,Hongzhuan Chen,Chao Fang
标识
DOI:10.1002/adfm.202214842
摘要
Abstract Living cell‐based drug delivery systems (LC‐DDSs) are limited by adverse interactions between drugs and carrier cells, typically drug‐induced toxicity to carrier cells and restriction of carrier cells on drug release. Here, a method is established to adsorb nanocarriers externally to living cells, thereby reducing cytotoxicity caused by drug uptake and realizing improved drug release at the disease site. It is found that a divalent metal ion‐phenolic network (MPN) affords adhesion of poly (lactic‐co‐glycolic acid) nanoparticles onto macrophage (Mφ) surfaces with minimized intracellular uptake and no negative effect on cell proliferation. On this basis, an Mφ‐DDS with doxorubicin‐loaded nanoparticles on cell surface (DOX‐NP@Mφ) is constructed. Compared to intracellular loading via endocytosis, this method well‐maintains bioactivity (viability and migration chemotaxis) of the carrier cell. By virtue of the photothermal effect of MPN at the tumor site, DOX‐NP‐associated vesicles are liberated for improved chemotherapy. This facile, benign, and efficient method (ice bath, 2 min) for extracellular nanoparticle attachment and minimizing intracellular uptake provides a platform technology for LC‐DDS development.
科研通智能强力驱动
Strongly Powered by AbleSci AI